drugset / Trial / NCT05161845
Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
NaSingle-groupOpen-labelPrevention
Summary
To evaluate the immunogenicity, lot-to-lot consistency and safety of three consecutive batches of Measles, Mumps and Rubella Combined Vaccine, Live.
Timeline
- Start
- 2021-12-23
- Primary completion
- 2022-04-04
- Completion
- 2022-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Measles, Mumps and Rubella Combined Vaccine, Live | Vaccine | 0.5 ml | — |